Feds: Morning-after pill appeal officially on hold

by Tom Hays
This undated file photo provided by Barr Pharmaceuticals Inc., shows a package of Plan B One-Step, an emergency contraceptive. The federal government on Monday, June 10, 2013 told a judge it will reverse course and take steps to comply with his order to allow girls of any age to buy emergency contraception without prescriptions. (AP Photo/Barr Pharmaceuticals Inc., File)

A government appeal in the legal fight over allowing girls of any age to buy emergency contraception without prescriptions has officially been put on hold.

said Tuesday in a letter to a New York City appeals court both sides have agreed to stop litigating while they await a ruling from a lower-court judge.

The Department of Justice notified U.S. District Judge Edward Korman on Monday it had decided to reverse course and comply with his order to allow sales of the morning-after pills without age or other restrictions. It said it would withdraw the appeal of the order if the judge agrees with its plan to fast-track approval.

It's unclear when and how the judge will address the issue. A woman answering the phone in his chambers declined to comment.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

US to allow morning-after pill for girls of any age

Jun 11, 2013

The Obama administration said Monday it would comply with a judge's order to allow women and girls of any age to purchase emergency contraception, ending its efforts to restrict the drug's availability.

Judge in NYC rips opposition to Plan B order

May 07, 2013

A federal judge, asked by the U.S. government on Tuesday to freeze his plan giving teenage girls broader access to morning-after birth control, instead seized the chance to accuse health officials of taking steps that would ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.